Skip to content

Clinical trials

Phase 2 Anorexia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anorexia Phase: Phase 2 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20062
20074
20111
20121
20211
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting2
Enrolling by invitation1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Eisai Inc.2
Amanda Downey, MD1
Bristol-Myers Squibb1
Endo USA Inc., a Keenova Therapeutics Company1
Helsinn Therapeutics (U.S.), Inc1
Lahey Clinic1
Mayo Clinic1
Motus Therapeutics, Inc.1
New York State Psychiatric Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anorexia21
Cachexia8
Weight Loss8
Anorexia Nervosa6
Feeding and Eating Disorders5
Fatigue3
Obesity3
Overweight3
Body Weight Changes2
Colorectal Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.